Eger Markhot Ferenc Kórház

Eger 3300

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Relapsed/Refractory B Cell Malignancies, Small Lymphocytic Lymphoma, Treatment-Naive B Cell Malignancies

Studies at this site

• Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects — Status unconfirmed